Hikma Pharmaceuticals (LSE:HIK)

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Related Articles

• Tuesday, 19th March, 2019 | Roland Head

  2 dividend stocks I’d buy for an ISA today

  These dividend stocks could be big winners over the next decade, says Roland Head. Read More »

• Wednesday, 13th March, 2019 | G A Chester

  Could this FTSE 100 stock double your money again?

  G A Chester discusses the outlook for this FTSE 100 (INDEXFTSE:UKX) big winner and a smaller-cap peer. Read More »

• Wednesday, 27th February, 2019 | Peter Stephens

  Forget Bitcoin! I think buying these 2 pharma stocks could be a better way to get rich

  The healthcare segment may offer a stronger growth outlook than the virtual currency due to demographic change. Read More »

• Monday, 14th January, 2019 | Harvey Jones

  I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

  Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year. Read More »

• Monday, 24th December, 2018 | Alan Oscroft

  Can this year’s biggest FTSE 250 winners keep it going in 2019?

  2018 has been a great year for the top FTSE 250 (INDEXFTSE: MCX) stocks. Will 2019 see their strong run continuing? Read More »

• Thursday, 8th November, 2018 | Peter Stephens

  The BT share price soars by 20%. Here’s why I think it could beat the FTSE 100

  BT Group plc (LON: BT.A) could offer further growth potential versus the FTSE 100 (INDEXFTSE:UKX). Read More »

• Friday, 19th October, 2018 | Alan Oscroft

  FTSE 100 crash? Is this the best stock to hold in case it happens?

  Should you be looking for 'picks-and-shovels' plays in case the FTSE 100 (INDEXFTSE: UKX) is heading for a fall? Read More »

• Tuesday, 21st August, 2018 | Edward Sheldon, CFA

  Is Hikma Pharmaceuticals the hottest growth stock in the FTSE 250?

  FTSE 250 (INDEXFTSE: MCX) growth stock Hikma Pharmaceuticals plc (LON: HIK) is up 120% since March. Are there more gains to come? Read More »

• Wednesday, 15th August, 2018 | Kevin Godbold

  Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc

  I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN). Read More »

• Saturday, 4th August, 2018 | Jack Tang

  Why is the Burberry share price up 20% so far this year?

  Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround. Read More »